CA-125 Change After Chemotherapy in Prediction of Treatment Outcome Among Advanced Mucinous and Clear Cell Epithelial Ovarian Cancers

Cancer - United States
doi 10.1002/cncr.24152
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

The Prognostic Value of Morphometry in Advanced Epithelial Ovarian Cancers

British Journal of Cancer
Cancer ResearchOncology
1995English

Pre-Treatment Prediction of Chemoresistance in Second-Line Chemotherapy of Ovarian Carcinoma: Value of Serological Tumor Marker Determination (Tetranectin, YKL-40, CASA, CA 125)

International Journal of Biological Markers
OncologyCancer ResearchClinical BiochemistryForensic MedicineMedicinePathology
2006English

Genome-Wide Interrogation of Human Cancers Identifies EGLN1 Dependency in Clear Cell Ovarian Cancers

Cancer Research
Cancer ResearchOncology
2019English

Efficacy of Aidi Injection Combined With Chemotherapy in the Treatment of Advanced Epithelial Ovarian Cancer

DEStech Transactions on Biology and Health
2018English

Apatinib Treatment Combined With Chemotherapy for Advanced Epithelial Ovarian Cancer: A Case Report

OncoTargets and Therapy
OncologyPharmacology
2017English

Is Peritonectomy and Hyperthermic Intraperitoneal Chemotherapy a New Standard of Treatment for Advanced Epithelial Ovarian Cancer?

Australian and New Zealand Journal of Obstetrics and Gynaecology
MedicineGynecologyObstetrics
2019English

Cyclophosphamide "Metronomic" Chemotherapy for Palliative Treatment of a Young Patient With Advanced Epithelial Ovarian Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2007English

Neoadjuvant Chemotherapy for Advanced Epithelial Ovarian Cancer. Who Really Benefits?

Australian and New Zealand Journal of Obstetrics and Gynaecology
MedicineGynecologyObstetrics
2017English

Circulating IGF System and Treatment Outcome in Epithelial Ovarian Cancer

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy